Navigation Links
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Date:3/9/2009

hw-popup/uterine-fibroids" target="_new">fibroids from the uterus, and various types of transvaginal surgery.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System, which just received FDA clearance, and its CoolBlue(TM) System, please visit www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate(TM) is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
2. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
3. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
4. AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
5. AMA Foundation Announces Seed Grant Research Recipients
6. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
7. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
8. Premier Research Announces Milestone New Drug Application
9. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
10. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
11. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Boston Children,s Hospital,s Global Pediatric Summit + ... an "Innovation Tank" – a forum designed to give ... business or product solution to a panel of acclaimed ... to accelerate the innovation and bring it to market. ... October 31, will be moderated by Daymond John ...
(Date:7/24/2014)... , July 24, 2014  To help ... cardiovascular market that could impact patient care and ... 2014 CV Watch , "Innovations in Cardiovascular Devices."  ... hospitals with guidance and details on promising new ... needs and understand how these options impact the ...
(Date:7/24/2014)... part of its ongoing effort to help women pharmacists become ... Boot Camp on July 26 as part of the company,s ... The Boot Camp is designed to ... their own pharmacies.  Now in its third year, the Cardinal ... pharmacists who dream of owning a pharmacy.   ...
Breaking Medicine Technology:Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4
... Association of Clinical Research Organizations (ACRO), which represents the ... and the public in the U.S. and worldwide, issued ... Implications of the Globalization of Clinical Research" published in ... England Journal of Medicine : The article by ...
... Journal of Medicine employs Quest Diagnostics, blood-based leukemia testingMADISON, ... specimens may detect abnormal white blood cells in patients ... develops, according to research published in the current issue ... Medicine . The finding may lead to a better ...
Cached Medicine Technology:ACRO Comments on NEJM Article on Globalization of Clinical Research 2ACRO Comments on NEJM Article on Globalization of Clinical Research 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4
(Date:7/24/2014)... A new study led by the Translational Genomics Research ... viruses and the immune system during HIV infection. , ... to infect others based on their blood viral ... in their semen despite having low levels in their ... the virus can be found in different parts of ...
(Date:7/24/2014)... London, UK (PRWEB) July 24, 2014 Memantine ... and was first marketed in Germany under the brand name ... and other nations as Ebixa and in the USA to ... of USD 420 million in 2013. In the US, Forest ... , Patent protection expiry in Canada, Australia and the European ...
(Date:7/24/2014)... 24, 2014 Members of the Iowa State ... CCIM, Senior Associate of Sales at OutcomesMTM, as their Chairperson. ... to the Board and that his peers chose to keep ... provide the best I can for the citizens of Iowa,” ... positioned to provide a special insight to concerns and issues ...
(Date:7/24/2014)... In a recent report by CBS News, the district capital ... criminal penalties associated with possession of small amounts of marijuana. ... Washington DC, giving it one of the most tolerant marijuana ... possession of one ounce of marijuana or less with a ... an ounce of marijuana remain criminal offenses under the new ...
(Date:7/24/2014)... received the Human Papillomavirus Vaccination (HPV) even after ... Pap test results than those who were never ... Sexually Transmitted Diseases . , Researchers from ... of Medicine conducted a cross-sectional study of 235 ... cytology testing. HPV status and demographic and behavioral ...
Breaking Medicine News(10 mins):Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Wolnerman Re-elected as Chairperson of Iowa State Board of Health 2Health News:Washington D.C. Decriminalizes Marijuana 2
... Pilot animal study shows promising results in the treatment of ... ... (Vocus) September 9, 2008 -- A pilot animal ... Boston] provides preliminary evidence that delivering neural stem cells (NSC) ...
... WEXFORD, Penn., Sept. 9 Millennium Pharmacy Systems,Inc., ... enabled pharmacy,solutions to senior healthcare facilities, announced today ... Mr. Scardina has served on,the Millennium Board of ... as an independent consultant after serving as an ...
... TARRYTOWN, N.Y., Sept. 9 Focus 28, Inc. ... its new next generation line of,meal replacements and ... of bariatric patients. According to the company,Bariatric RX ... food,supplements also utilize Double A Technology (AAT), a ...
... Mark Jones and William Reed with colleagues at the ... use of Tasers related to ethnicity, gender, race and ... the Use of Conducted Energy Devices by the Houston ... "Conducted Energy Device Program Performance Audit," released by the ...
... 9 Governor Edward G.,Rendell today announced the ... as Secretary of the Pennsylvania Department of Health ... passionate voice for protecting and improving,the health of ... as an effective leader, addressing a variety of,issues ...
... for the Retirement ... month, NORTH CONWAY, N.H., Sept. 9 It,s no ... aging population grows, so,does the need to house them. According ... nursing homes, 39,500 assisted living,facilities and 1,900 continuing care retirement ...
Cached Medicine News:Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 3Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 4Health News:Focus 28 Begins Shipping Next Generation Line of Meal Replacements and Food Supplements for Bariatric Patients 2Health News:Rice political scientists co-author report on ethnic/racial aspects of Taser use by Houston police 2Health News:Governor Rendell Announces Resignation of Health Secretary Dr. Calvin Johnson 2Health News:SeniorHousingJobs.com Celebrates Its 5th Anniversary 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: